At-home test kits, new vaccine developments, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our weekly “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for this week.

1. A Chinese Coronavirus Vaccine Advances to Phase II Trials

CanSino Bio’s in-development coronavirus vaccine was the second in the world to reach human trials — and it’s now the first to advance to the second stage of human testing.

2. The FDA Authorizes the First At-Home Coronavirus Test Kit

For the first time, people have the option of collecting their own coronavirus samples at home, a development that could both increase access to testing and help prevent the spread of the coronavirus.

3. We May Need Fewer Ventilators for COVID-19 Patients Than We Expected

New research suggests that healthcare workers may be overusing ventilators for COVID-19 patients — meaning there might be more of the machines to go around than previously thought.

4. Microsoft’s “Plasma Bot” Helps You Donate Plasma for COVID-19

Microsoft created an online bot to help guide coronavirus survivors through the process of donating their antibody-rich plasma — a move that could help advance COVID-19 trials and research.

5. Ghana Is Using Drones to Speed Up Its Coronavirus Testing

The African nation of Ghana is using autonomous drones to transport coronavirus test samples from rural areas to two city labs — and the devices might be flying over the U.S. in the near future.

Related
OpenAI’s GPT-4 outperforms doctors in another new study
OpenAI’s most powerful AI model, GPT-4, outperformed junior doctors in deciding how to treat patients with eye problems.
AI can help predict whether a patient will respond to specific tuberculosis treatments
Instead of a one-size-fits-all treatment approach, AI could help personalize treatments for each patient to provide the best outcomes.
In a future with brain-computer interfaces like Elon Musk’s Neuralink, we may need to rethink freedom of thought
In a future with more “mind reading,” thanks to computer-brain interfaces, we may need to rethink freedom of thought.
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
Up Next
Subscribe to Freethink for more great stories